Compare Heron Therapeutics Inc (HRTX) vs Pfizer Inc (PFE) Price & Performance

Heron Therapeutics IncTrade

Pfizer IncTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Pfizer Inc — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Pfizer Inc trades at $26.28 (market cap $151.73B). The key difference: Pfizer Inc is far larger — about 2468.4× Heron Therapeutics Inc's market cap, and Pfizer Inc pays a 6.46% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.

	HRTX	PFE
Market Cap	$61.47M	$151.73B
Sector	Health	Health
52-Week High	$1.49	$28.56
52-Week Low	$0.32	$23.60
Enterprise Value	$168.21M	$203.22B
Volume	—	29,869,932
Dividend Yield	—	6.46%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

No Aura AI signal available yet.

Pfizer Inc

Pfizer (PFE) trades at $27.05, up 1.16% with a bullish technical signal and consistent earnings beats in recent quarters. Revenue remains stable around $62-63 billion, though net income is projected to decline in 2026. The stock shows strong profitability margins and a solid balance sheet, but faces headwinds from patent expirations and competitive pressures.

The outlook is mixed: valuation multiples appear reasonable, and analyst consensus leans hold with a $27.86 target. Key risks include execution on pipeline catalysts and margin compression. Upside depends on successful drug launches and cost management amid a challenging revenue environment.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HRTX

Heron Therapeutics misses Q2 earnings and revenue estimates, pauses sales expansion, withdraws full-year outlook.Alex Lavoie · 1 day agoBearish View details →

PFE

Revolution Medicines hits $44B market cap with breakthrough RAS cancer drugs, attracting big pharma interest.24/7 Wall Street · 4 hours agoBullish Five S&P 500 stocks offer 6%+ dividends, ideal for income-focused investors seeking growth and stability.24/7 Wall Street · 5 hours agoBullish Pfizer shows growth and earnings beat, with strong cost savings and 30% return potential.Seeking Alpha · 20 hours agoBullish View details →

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

About Pfizer Inc

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.